Pages that link to "Q80282021"

The following pages link to A genetic mouse model for metastatic lung cancer with gender differences in survival (Q80282021):

Displaying 48 items.

• WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis (Q24310644) (← links)
• Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression (Q24647373) (← links)
• Smoking, p53 mutation, and lung cancer (Q27014977) (← links)
• Quantitative ex-vivo micro-computed tomographic imaging of blood vessels and necrotic regions within tumors (Q27330382) (← links)
• Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes (Q27333989) (← links)
• Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models (Q27687650) (← links)
• Novel insights into the molecular origins and treatment of lung cancer (Q28386773) (← links)
• The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. (Q28389376) (← links)
• Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer (Q28505734) (← links)
• Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma (Q33436727) (← links)
• ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism (Q33685931) (← links)
• DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization (Q33773787) (← links)
• Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers (Q33851540) (← links)
• Obligate progression precedes lung adenocarcinoma dissemination (Q33875584) (← links)
• Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression (Q34417878) (← links)
• Circulating tumor cells from 4D model have less integrin beta 4 expression (Q34717466) (← links)
• Identification of fat4 and tsc22d1 as novel candidate genes for spontaneous pulmonary adenomas (Q35190649) (← links)
• Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma. (Q36078222) (← links)
• BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells (Q36086181) (← links)
• The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL (Q36428009) (← links)
• CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma (Q36544886) (← links)
• Estrogen metabolism within the lung and its modulation by tobacco smoke (Q36740713) (← links)
• Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. (Q37040720) (← links)
• SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans (Q37309854) (← links)
• Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer (Q37690890) (← links)
• ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression (Q38323022) (← links)
• Trp53 Mutants Drive Neuroendocrine Lung Cancer through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response (Q38605143) (← links)
• Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication (Q38844605) (← links)
• Map2k4 Functions as a Tumor Suppressor in Lung Adenocarcinoma and Inhibits Tumor Cell Invasion by Decreasing Peroxisome Proliferator-Activated Receptor γ2 Expression (Q38960209) (← links)
• A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model (Q39284790) (← links)
• Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. (Q39460209) (← links)
• Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models. (Q39499534) (← links)
• The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice (Q39576164) (← links)
• miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. (Q39640226) (← links)
• Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis (Q39923466) (← links)
• DNA mismatch repair deficiency accelerates lung neoplasm development in K-ras(LA1/+) mice: a brief report (Q41829637) (← links)
• Multiple Stress Signals Activate Mutant p53 In Vivo (Q41890892) (← links)
• ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma. (Q42143482) (← links)
• Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development (Q42330439) (← links)
• PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer (Q42493887) (← links)
• An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients. (Q53072915) (← links)
• TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins. (Q55724715) (← links)
• Autochthonous murine models for the study of smoker and never-smoker associated lung cancers (Q58804389) (← links)
• In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer (Q61136513) (← links)
• Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse (Q64097437) (← links)
• A new mouse model to study the role of ectopic Nanos3 expression in cancer. (Q64968281) (← links)
• You can win by losing: p53 mutations in rhabdomyosarcomas (Q84991066) (← links)
• MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs (Q99608553) (← links)